Revenue
$62.9M
▲ 699.0% YoY
Net Income
-$204.6M
▲ 64.0% YoY
EPS
$-0.60
▲ 71.6% YoY
Cash
$164.1M
▲ 359.3% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Wentworth Kerry CHIEF REGULATORY OFFICER | Vest | Apr 17, 2026 | 36.8K | $2.93 | $108K | Form 4 ↗ |
Wentworth Kerry CHIEF REGULATORY OFFICER | Sell | Apr 17, 2026 | 36.8K | $5.01 | $184K | Form 4 ↗ |
Liu Dongfang CHIEF MEDICAL OFFICER | Vest | Apr 17, 2026 | 50.0K | $1.94 | $97K | Form 4 ↗ |
Liu Dongfang CHIEF MEDICAL OFFICER | Sell | Apr 17, 2026 | 50.0K | $5.02 | $251K | Form 4 ↗ |
Wentworth Kerry CHIEF REGULATORY OFFICER | Vest | Apr 6, 2026 | 100.0K | $1.87 | $187K | Form 4 ↗ |
Wentworth Kerry CHIEF REGULATORY OFFICER | Vest | Apr 6, 2026 | 100.0K | $1.94 | $194K | Form 4 ↗ |
Wentworth Kerry CHIEF REGULATORY OFFICER | Sell | Apr 6, 2026 | 200.0K | $4.52 | $904K | Form 4 ↗ |
Makunje Moses SEE REMARKS | Grant | Feb 27, 2026 | 50.8K | $0.00 | $0 | Form 4 ↗ |